Clinical and radiological characteristics of patients with spontaneous and post-traumatic subarachnoid hemorrhage: a retrospective observational study
Abstract
Background/Aim. Several serious complications can accompany both spontaneous and post-traumatic subarachnoid hemorrhage (SAH) such as the development of intracranial hypertension, hydrocephalus, re-bleeding, cerebral hypoxia, cerebral vasospasm, impaired pituitary function, electrolyte imbalance, and electrocardiographic (ECG) abnormalities. Although there is a declining trend in mortality, the treatment of SAH and its complications represents a challenge even in imposing neurosurgical centers. The aim of the study was to compare some clinical characteristics and complications between spontaneous and post-traumatic SAH. Methods. The retrospective study included 138 patients treated at the Department of Neurosurgery from January 2018 to January 2023. There were 71 patients with spontaneous and 67 patients with post-traumatic SAH. Results. A predominance of spontaneous SAH in female and post-traumatic SAH in male patients (p < 0.001) was found. There was a statistically significant difference in the frequency of hydrocephalus between groups of spontaneous and post-traumatic SAH patients (p = 0.013). Cerebral vasospasm was significantly more prevalent in patients with spontaneous SAH (p < 0.001). A statistically significant association was also obtained between the thickness of the coagulum in these two groups (p < 0.001). Patients with spontaneous SAH were significantly more likely to have a negative T wave in ECG findings (p < 0.001). Furthermore, there was no statistically significant difference regarding electrolyte imbalance in these two groups of patients with SAH. Conclusion. There were statistically significant differences between gender distribution, the frequency of abnormal ECG findings in the form of a negative T wave, greater coagulum thickness, vasospasm occurrence, and a higher rate of hydrocephalus in patients with spontaneous SAH compared to patients with post-traumatic SAH.
References
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 2014; 129(3): e28–292.
Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and sys-tematic review. Neurology 2010; 74(19): 1494–501.
Muehlschlegel S. Subarachnoid Hemorrhage. Continuum (Min-neap Minn) 2018; 24(6): 1623–57.
van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007; 369(9558): 306–18.
Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998; 29(1): 251–6.
Macdonald RL, Schweizer TA. Spontaneous subarachnoid haem-orrhage. Lancet 2017; 389(10069): 655–66.
Griswold DP, Fernandez L, Rubiano AM. Traumatic subarach-noid hemorrhage: a scoping review. J Neurotrauma 2022; 39(1–2): 35–48.
Modi NJ, Agrawal M, Sinha VD. Post-traumatic subarachnoid hemorrhage: A review. Neurol India 2016; 64(Suppl): S8–13.
Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009; 31(2): 151–8.
Weir B. Unruptured intracranial aneurysms: a review. J Neuro-surg 2002; 96(1): 3–42.
Huang H, Lai LT. Incidence and case-fatality of aneurysmal subarachnoid hemorrhage in Australia, 2008–2018. World Neurosurg 2020; 144: e438–46.
Bracard S, Anxionnat R, Picard L. Current diagnostic modalities for intracranial aneurysms. Neuroimaging Clin N Am 2006; 16(3): 397–441.
de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007; 78(12): 1365–72.
Algra AM, Klijn CJ, Helmerhorst FM, Algra A, Rinkel GJ. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology 2012; 79(12): 1230–6.
Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 2009; 40(6): 1963–8.
Turan N, Heider RA, Zaharieva D, Ahmad FU, Barrow DL, Pradilla G. Sex differences in the formation of intracranial aneurysms and incidence and outcome of subarachnoid hemorrhage: review of experimental and human studies. Transl Stroke Res 2016; 7(1): 12–9.
Escobar JM, García JP, González LD, Restrepo Bravo CA. Electrocardiographic abnormalities in subarachnoid hemorrhage. Cardiovasc Metab Sci 2019; 30(4): 136–42.
Zaroff JG, Rordorf GA, Newell BA, Ogilvy CS, Levinson JR. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery 1999; 44(1): 34–40.
Littmann L, Gibbs MA. Electrocardiographic manifestations of severe hyperkalemia. J Electrocardiol 2018; 51(5): 814–7.
Wang X, Han D, Li G. Electrocardiographic manifestations in severe hypokalemia. J Int Med Res 2020; 48(1): 300060518811058.
Zhang L, Qi S. Electrocardiographic abnormalities predict ad-verse clinical outcomes in patients with subarachnoid hemor-rhage. J Stroke Cerebrovasc Dis 2016; 25(11): 2653–9.
Brouwers PJ, Wijdicks EF, Hasan D, Vermeulen M, Wever EF, Frericks H, et al. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke 1989; 20(9): 1162–7.
Naval NS, Stevens RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med 2006; 34(2): 511–24.
Ridwan S, Zur B, Kurscheid J, Esche J, Kristof R, Klingmüller D, et al. Hyponatremia after spontaneous aneurysmal subarachnoid hemorrhage—a prospective observational study. World Neu-rosurg 2019; 129: e538–44.
See AP, Wu KC, Lai PM, Gross BA, Du R. Risk factors for hy-ponatremia in aneurysmal subarachnoid hemorrhage. J Clin Neurosci 2016; 32: 115–8.
Mapa B, Taylor BE, Appelboom G, Bruce EM, Claassen J, Connolly ES Jr. Impact of hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage: a systematic review. World Neurosurg 2016; 85: 305–14.
Kieninger M, Kerscher C, Bründl E, Bele S, Proescholdt M, Zeman F, et al. Acute hyponatremia after aneurysmal subarachnoid hemorrhage: frequency, treatment, and outcome. J Clin Neu-rosci 2021; 88: 237–42.
Cui H, He G, Yang S, Lv Y, Jiang Z, Gang X, et al. Inappropriate antidiuretic hormone secretion and cerebral salt-wasting syndromes in neurological patients. Front Neurosci 2019; 13: 1170.
Nakajima H, Okada H, Hirose K, Murakami T, Shiotsu Y, Kadono M, et al. Cerebral salt-wasting syndrome and inappropriate an-tidiuretic hormone syndrome after subarachnoid hemorrhag-ing. Intern Med 2017; 56(6): 677–80.
Aleksandrowicz M, Kozniewska E. Hyponatremia as a risk factor for microvascular spasm following subarachnoid hemorrhage. Exp Neurol 2022; 355: 114126.
Ybanez N, Agrawal V, Tranmer BI, Gennari FJ. Severe hypoka-lemia in a patient with subarachnoid hemorrhage. Am J Kid-ney Dis 2014; 63(3): 530–5.
Tam CW, Shum HP, Yan WW. Impact of Dysnatremia and Dyskalemia on Prognosis in Patients with Aneurysmal Sub-arachnoid Hemorrhage: A Retrospective Study. Indian J Crit Care Med 2019; 23(12): 562–7.
Merkel H, Lindner D, Gaber K, Ziganshyna S, Jentzsch J, Mucha S, et al. Standardized Classification of Cerebral Vasospasm after Subarachnoid Hemorrhage by Digital Subtraction Angi-ography. J Clin Med 2022; 11(7): 2011.
Levine JM. Critical care management of subarachnoid hemor-rhage. Curr Treat Options Neurol 2009; 11(2): 126–36.
Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after an-eurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg 2011; 76(5): 446–54.
Lukić S, Mijailović M, Marković Z, Janković SM, Nikolić R. Embolization of ruptured intracranial aneurysms with detachable coils: case series. Jpn J Radiol 2011; 29(2): 92–7.
Kovacevic V, Peulic M, Nikolic R, Mijailovic M, Lukic S, Miletic-Kovacevic M, et al. Cerebral vasospasm after aneurysmal sub-arachnoid hemorrhage, management and treatment outcome. PONS Med J 2012; 10(1): 17–23.
Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a pro-spective study. Neurology 1983; 33(4): 424–36.
Smith ML, Abrahams JM, Chandela S, Smith MJ, Hurst RW, Le Roux PD. Subarachnoid hemorrhage on computed tomography scanning and the development of cerebral vasospasm: the Fisher grade revisited. Surg Neurol 2005; 63(3): 229–34.
Melinosky C, Kincaid H, Claassen J, Parikh G, Badjatia N, Morris NA. The Modified Fisher Scale Lacks Interrater Reliabil-ity. Neurocrit Care 2021; 35(1): 72–8.
Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, et al. Prediction of symptomatic vasospasm af-ter subarachnoid hemorrhage: the modified Fisher scale. Neu-rosurgery 2006; 59(1): 21–7.
Macdonald RL. Delayed neurological deterioration after sub-arachnoid haemorrhage. Nat Rev Neurol 2014; 10(1): 44–58.
Wong GK, Poon WS. Clazosentan for patients with subarach-noid haemorrhage: lessons learned. Lancet Neurol 2011; 10(10): 871; author reply 871–2.
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). Acta Neurochir Suppl 2013; 115: 27–31.
Grasso G, Alafaci C, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives. Surg Neurol Int 2017; 8: 11.
Grasso G, Buemi M, Giambartino F. The role of erythropoietin in aneurysmal subarachnoid haemorrhage: from bench to bed-side. Acta Neurochir Suppl 2015; 120: 75–80.
Tso MK, Ibrahim GM, Macdonald RL. Predictors of shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage. World Neurosurg 2016; 86: 226–32.
Germanwala AV, Huang J, Tamargo RJ. Hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21(2): 263–70.
Lu J, Ji N, Yang Z, Zhao X. Prognosis and treatment of acute hydrocephalus following aneurysmal subarachnoid haemor-rhage. J Clin Neurosci 2012; 19(5): 669–72.
Bhattacharjee S, Rakesh D, Ramnadha R, Manas P. Subarachnoid Hemorrhage and Hydrocephalus. Neurol India 2021; 69(Supplement): S429–33.
Kwon JH, Sung SK, Song YJ, Choi HJ, Huh JT, Kim HD. Predis-posing factors related to shunt-dependent chronic hydro-cephalus after aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc 2008; 43(4): 177–81.
Rincon F, Gordon E, Starke RM, Buitrago MM, Fernandez A, Schmidt JM, et al. Predictors of long-term shunt-dependent hy-drocephalus after aneurysmal subarachnoid hemorrhage. Clini-cal article. J Neurosurg 2010; 113(4): 774–80.
O'Kelly CJ, Kulkarni AV, Austin PC, Urbach D, Wallace MC. Shunt-dependent hydrocephalus after aneurysmal subarach-noid hemorrhage: Incidence, predictors, and revision rates. J Neurosurg 2009; 111(5): 1029–35.
Xie Z, Hu X, Zan X, Lin S, Li H, You C. Predictors of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage? A systematic review and meta-analysis. World Neurosurg 2017; 106: 844–60. e6.
Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg 2013; 79(2): 307–12.
Cha KC, Kim JH, Kang HI, Moon BG, Lee SJ, Kim JS. Aneurys-mal rebleeding: factors associated with clinical outcome in the rebleeding patients. J Korean Neurosurg Soc 2010; 47(2): 119–23.
Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001; 32(5): 1176–80.
Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Ultra-early rebleeding in spontaneous subarachnoid hemor-rhage. J Neurosurg 1996; 84(1): 35–42.
Gruber A, Dietrich W, Czech T, Richling B. Recurrent aneurysmal subarachnoid haemorrhage: bleeding pattern and incidence of posthaemorrhagic ischaemic infarction. Br J Neurosurg 1997; 11(2): 121–6.
Beck J, Raabe A, Szelenyi A, Berkefeld J, Gerlach R, Setzer M, et al. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke 2006; 37(11): 2733–7.
van Donkelaar CE, Bakker NA, Veeger NJ, Uyttenboogaart M, Metzemaekers JD, Luijckx GJ, et al. Predictive factors for re-bleeding after aneurysmal subarachnoid hemorrhage: rebleed-ing aneurysmal subarachnoid hemorrhage study. Stroke 2015; 46(8): 2100–6.
Neifert SN, Chapman EK, Martini ML, Shuman WH, Schupper AJ, Oermann EK, et al. Aneurysmal subarachnoid hemorrhage: the last decade. Transl Stroke Res 2021; 12(3): 428–46.